Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C
Author(s) -
Celal Ayaz,
Mustafa Kemal Çelen,
Ugur Nedim Yuce,
Mehmet Faruk Geyik
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.255
Subject(s) - medicine , hemodialysis , gastroenterology , pegylated interferon , hepatitis c , group b , prospective cohort study , anemia , alpha interferon , hepatitis b , surgery , ribavirin , chronic hepatitis , interferon , immunology , virus
To evaluate the efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom